Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
M.J. Lozano de la Torre.
Fórmulas antirregurgitación: ¿tienen alguna indicación?.
An Esp Pediatr, 53 (2000), pp. 501
[2.]
A. Ballabriga, M. Moya, M. Bueno, J. Cornellá, J. Dalmau, R. Domenech.
Indicaciones de las fórmulas antirregurgitación.
An Esp Pediatr, 52 (2000), pp. 369-371
[3.]
Y. Vandenplas, D. Belly, P. Benhamou, S. Cadranel, J.P. Cezard, S. Cucchiara.
A critical appraisal of current management practices for infant regurgitation: recomendations of a working party.
Eur J Pediatr, 156 (1997), pp. 343-357
[4.]
Y. Vandenplas, D. Belly, S. Cadranel, S. Cucchiara Q, C. Dupont, H. Heymans.
Dietary treatment for regurgitation: recomendations from a working party.
Acta Paediatr, 87 (1998), pp. 462-468
[5.]
S.R. Orestein, H.L. Magill, P. Brooks.
Thickening of infants feedings for therapy of gastroesophageal reflux.
J Pediatr, 110 (1987), pp. 181-186
[6.]
J.A. Vanderhoof, S. Mehra, E. Bailey, W.J. Kagey, E.J. Slosberg, J.R . Moran.
Efficacy of thickening formulas in children with GERD symptoms.
Pediatr Research, 45 (1999), pp. 118A
[7.]
W. Tolia, C.H. Lin, L.R. Khuns.
Gastric emptymg using three different formulas in infant with gastroesophageal reflux.
J Pediatr Gastroenterol Nutr, 15 (1992), pp. 297-301
[8.]
Working group on motility disorders and GERD. World Congressof Pediatric Gastroenterology, Hepatology and Nutrition.August 5-9,2000. Report of the Working groups, 2000;194-203
[9.]
Y. Vandenplas.
ESPGHAN Cisapride Panel. Current indications for cisapride.
J Pediatr Gastroenterol Nutr, 31 (2000), pp. 480-489
[10.]
S.P. Nelson, E.H. Chen, G.M. Syniar, K.K. Christoffel.
Prevalence of symptoms of gastroesophageal reflux during infancy. A pediatric practice-based survey. Pediatric Practice Research Group.
Arch Pediatr Adolesc Med, 151 (1997), pp. 569-572
Copyright © 2001. Asociación Española de Pediatría
